Skip to content
PubMed This is a summary of 127 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 127 referenced papers

Top Authors

Richard Pötter
Comprehensive Cancer Center Vienna
Ina M. Jürgenliemk‐Schulz
University Medical Center Utrecht
Kari Tanderup
Aarhus University Hospital
Jacob Christian Lindegaard
Aarhus University Hospital
Christian Kirisits
Comprehensive Cancer Center Vienna
Alina Sturdza
Comprehensive Cancer Center Vienna
Kathrin Kirchheiner
Comprehensive Cancer Center Vienna
Pedro T. Ramírez
Methodist Hospital
Umesh Mahantshetty
Homi Bhabha National Institute
Remi A. Nout
Erasmus MC Cancer Institute

Top Institutions

Ranked by publications Top 10 institutions
05

Chinese Academy of Medical Sciences & Peking Union Medical College

Beijing, China

69 papers

References

References (127)
  1. 1

    Long-term health consequences of premature or early menopause and considerations for management.

    Faubion SS, Kuhle CL, Shuster LT, Rocca WA

    Climacteric : the journal of the International Menopause Society 2015; (18(4)):483-91 doi:10.3109/13697137.2015.1020484.

    PMID: 25845383
  2. 2

    Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

    Eleje GU, Eke AC, Igberase GO, et al.

    The Cochrane database of systematic reviews 2015; CD011000 doi:10.1002/14651858.CD011000.pub2.

    PMID: 25932968
  3. 3

    Management of Early Stage Cervical Cancer.

    Somashekhar SP, Ashwin KR

    Reviews on recent clinical trials 2015; (10(4)):302-8 doi:10.2174/1574887110666150923113629.

    PMID: 26411950
  4. 4

    Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort.

    Trifiletti DM, Swisher-McClure S, Showalter TN, et al.

    International journal of radiation oncology, biology, physics 2015; (93(5)):1032-44.

    PMID: 26581141
  5. 5

    Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.

    Kirchheiner K, Nout RA, Lindegaard JC, et al.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2016; (118(1)):160-6.

    PMID: 26780997
  6. 6

    Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update.

    Elit L, Kennedy EB, Fyles A, Metser U

    Current oncology (Toronto, Ont.) 2016; (23(2)):109-18 doi:10.3747/co.23.2742.

    PMID: 27122975
  7. 7

    Current imaging strategies for the evaluation of uterine cervical cancer.

    Bourgioti C, Chatoupis K, Moulopoulos LA

    World journal of radiology 2016; (8(4)):342-54 doi:10.4329/wjr.v8.i4.342.

    PMID: 27158421
  8. 8

    Clinical Scenarios in Acute Kidney Injury: Post-Renal Acute Kidney Injury.

    Meola M, Samoni S, Petrucci I, Ronco C

    Contributions to nephrology 2016; (188()):64-8 doi:10.1159/000445468.

    PMID: 27170168
  9. 9

    Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.

    Tanderup K, Fokdal LU, Sturdza A, et al.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2016; (120(3)):441-446 doi:10.1016/j.radonc.2016.05.014.

    PMID: 27350396
  10. 10

    Prognostic Factors and Treatment Outcome for Patients with Stage IVB Cervical Cancer.

    Oishi S, Kudaka W, Toita T, et al.

    Anticancer research 2016; (36(7)):3471-5.

    PMID: 27354610
  11. 11

    Differences in outcome for cervical cancer patients treated with or without brachytherapy.

    Karlsson J, Dreifaldt AC, Mordhorst LB, Sorbe B

    Brachytherapy 2017; (16(1)):133-140 doi:10.1016/j.brachy.2016.09.011.

    PMID: 27836496
  12. 12

    Carcinogenic human papillomavirus infection.

    Schiffman M, Doorbar J, Wentzensen N, et al.

    Nature reviews. Disease primers 2016; (2()):16086 doi:10.1038/nrdp.2016.86.

    PMID: 27905473
  13. 13

    The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I-II cervical cancer: A review.

    Takekuma M, Kasamatsu Y, Kado N, et al.

    The journal of obstetrics and gynaecology research 2017; (43(4)):617-626 doi:10.1111/jog.13282.

    PMID: 28190285
  14. 14

    Is parametrectomy always necessary in early-stage cervical cancer?

    Baiocchi G, de Brot L, Faloppa CC, et al.

    Gynecologic oncology 2017; (146(1)):16-19 doi:10.1016/j.ygyno.2017.03.514.

    PMID: 28392128
  15. 15

    5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.

    Morel A, Baguet A, Perrard J, et al.

    Oncotarget 2017; (8(28)):46163-46176 doi:10.18632/oncotarget.17575.

    PMID: 28521287
  16. 16

    Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.

    Wang W, Hou X, Yan J, et al.

    BMC cancer 2017; (17(1)):510 doi:10.1186/s12885-017-3503-2.

    PMID: 28764676
  17. 17

    High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.

    Wallace NA, Khanal S, Robinson KL, et al.

    Journal of virology 2017; (91(20)) doi:10.1128/JVI.01084-17.

    PMID: 28768872
  18. 18

    The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.

    Graham SV

    Clinical science (London, England : 1979) 2017; (131(17)):2201-2221 doi:10.1042/CS20160786.

    PMID: 28798073
  19. 19

    The natural history of human papillomavirus infection.

    de Sanjosé S, Brotons M, Pavón MA

    Best practice & research. Clinical obstetrics & gynaecology 2018; (47()):2-13 doi:10.1016/j.bpobgyn.2017.08.015.

    PMID: 28964706
  20. 20

    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.

    Laan JJ, van Lonkhuijzen LRCW, van Os RM, et al.

    Gynecologic oncology 2017; (147(3)):684-689 doi:10.1016/j.ygyno.2017.10.013.

    PMID: 29074259
  21. 21

    Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.

    Ning MS, Ahobila V, Jhingran A, et al.

    Gynecologic oncology 2018; (148(1)):132-138 doi:10.1016/j.ygyno.2017.10.017.

    PMID: 29089122
  22. 22

    Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.

    Taplitz RA, Kennedy EB, Bow EJ, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018; (36(14)):1443-1453 doi:10.1200/JCO.2017.77.6211.

    PMID: 29461916
  23. 23

    Cervical Cancer Incidence in Young U.S. Females After Human Papillomavirus Vaccine Introduction.

    Guo F, Cofie LE, Berenson AB

    American journal of preventive medicine 2018; (55(2)):197-204 doi:10.1016/j.amepre.2018.03.013.

    PMID: 29859731
  24. 24

    Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.

    Matsuo K, Blake EA, Machida H, et al.

    Gynecologic oncology 2018; (150(3)):501-508 doi:10.1016/j.ygyno.2018.07.016.

    PMID: 30054103
  25. 25

    Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges.

    Boussios S, Cooke D, Hayward C, et al.

    Anticancer research 2018; (38(9)):4987-4997 doi:10.21873/anticanres.12817.

    PMID: 30194142
  26. 26

    Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer.

    Nama V, Angelopoulos G, Twigg J, et al.

    The Cochrane database of systematic reviews 2018; (10()):CD011478 doi:10.1002/14651858.CD011478.pub2.

    PMID: 30311942
  27. 27

    Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.

    Ramirez PT, Frumovitz M, Pareja R, et al.

    The New England journal of medicine 2018; (379(20)):1895-1904 doi:10.1056/NEJMoa1806395.

    PMID: 30380365
  28. 28

    Risk Factors for Ureteral Stricture After Radiochemotherapy Including Image Guided Adaptive Brachytherapy in Cervical Cancer: Results From the EMBRACE Studies.

    Fokdal L, Tanderup K, Pötter R, et al.

    International journal of radiation oncology, biology, physics 2019; (103(4)):887-894 doi:10.1016/j.ijrobp.2018.11.006.

    PMID: 30419309
  29. 29

    The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

    Hu Z, Ma D

    Cancer medicine 2018; (7(10)):5217-5236 doi:10.1002/cam4.1501.

    PMID: 30589505
  30. 30

    Revised FIGO staging for carcinoma of the cervix uteri.

    Bhatla N, Berek JS, Cuello Fredes M, et al.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019; (145(1)):129-135 doi:10.1002/ijgo.12749.

    PMID: 30656645
  31. 31

    Uterine Artery Pseudoaneurysm: A Life-Threatening Cause of Vaginal Bleeding in the Emergency Department.

    Jennings L, Presley B, Krywko D

    The Journal of emergency medicine 2019; (56(3)):327-331 doi:10.1016/j.jemermed.2018.12.016.

    PMID: 30685218
  32. 32

    Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.

    Eleje GU, Eke AC, Igberase GO, et al.

    The Cochrane database of systematic reviews 2019; (3()):CD011000 doi:10.1002/14651858.CD011000.pub3.

    PMID: 30888060
  33. 33

    HRT for women with premature ovarian insufficiency: a comprehensive review.

    Webber L, Anderson RA, Davies M, et al.

    Human reproduction open 2017; (2017(2)):hox007 doi:10.1093/hropen/hox007.

    PMID: 30895225
  34. 34

    Smoking Cessation Treatment Needs of Low SES Cervical Cancer Survivors.

    Hoover DS, Spears CA, Vidrine DJ, et al.

    American journal of health behavior 2019; (43(3)):606-620 doi:10.5993/AJHB.43.3.14.

    PMID: 31046890
  35. 35

    Second primary anal and oropharyngeal cancers in cervical cancer survivors.

    Papatla K, Halpern MT, Hernandez E, et al.

    American journal of obstetrics and gynecology 2019; (221(5)):478.e1-478.e6 doi:10.1016/j.ajog.2019.05.025.

    PMID: 31128108
  36. 36

    Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.

    Tan S, Tao Z, Bian X, et al.

    European journal of obstetrics, gynecology, and reproductive biology 2019; (241()):99-103 doi:10.1016/j.ejogrb.2019.08.020.

    PMID: 31484100
  37. 37

    Ovarian damage from chemotherapy and current approaches to its protection.

    Spears N, Lopes F, Stefansdottir A, et al.

    Human reproduction update 2019; (25(6)):673-693 doi:10.1093/humupd/dmz027.

    PMID: 31600388
  38. 38

    Oncologic Emergencies: The Fever With Too Few Neutrophils.

    Long B, Koyfman A

    The Journal of emergency medicine 2019; (57(5)):689-700 doi:10.1016/j.jemermed.2019.08.009.

    PMID: 31635928
  39. 39

    The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.

    McComas KN, Torgeson AM, Ager BJ, et al.

    Gynecologic oncology 2020; (156(1)):85-92 doi:10.1016/j.ygyno.2019.10.025.

    PMID: 31744640
  40. 40

    Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate.

    Machida H, Iwata T, Okugawa K, et al.

    Gynecologic oncology 2020; (156(2)):341-348 doi:10.1016/j.ygyno.2019.11.021.

    PMID: 31767188
  41. 41

    Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.

    Arbyn M, Weiderpass E, Bruni L, et al.

    The Lancet. Global health 2020; (8(2)):e191-e203 doi:10.1016/S2214-109X(19)30482-6.

    PMID: 31812369
  42. 42

    Changing treatment landscape for early cervical cancer: outcomes reported with minimally invasive surgery compared with an open approach.

    Melamed A, Ramirez PT

    Current opinion in obstetrics & gynecology 2020; (32(1)):22-27 doi:10.1097/GCO.0000000000000598.

    PMID: 31815768
  43. 43

    Chemoradiotherapy is not superior to radiotherapy alone after radical surgery for cervical cancer patients with intermediate-risk factor.

    Kim H, Park W, Kim YS, Kim YJ

    Journal of gynecologic oncology 2020; (31(3)):e35 doi:10.3802/jgo.2020.31.e35.

    PMID: 31912685
  44. 44

    A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System.

    Liu X, Wang W, Hu K, et al.

    Scientific reports 2020; (10(1)):362 doi:10.1038/s41598-019-57202-3.

    PMID: 31941966
  45. 45

    Effectiveness of modified complex decongestive physiotherapy for preventing lower extremity lymphedema after radical surgery for cervical cancer: a randomized controlled trial.

    Wang X, Ding Y, Cai HY, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(6)):757-763 doi:10.1136/ijgc-2019-000911.

    PMID: 32107315
  46. 46

    FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.

    Grigsby PW, Massad LS, Mutch DG, et al.

    Gynecologic oncology 2020; (157(3)):639-643 doi:10.1016/j.ygyno.2020.03.027.

    PMID: 32248993
  47. 47

    A Review of Cervical Cancer: Incidence and Disparities.

    Buskwofie A, David-West G, Clare CA

    Journal of the National Medical Association 2020; (112(2)):229-232 doi:10.1016/j.jnma.2020.03.002.

    PMID: 32278478
  48. 48

    Subversion of Host Innate Immunity by Human Papillomavirus Oncoproteins.

    Lo Cigno I, Calati F, Albertini S, Gariglio M

    Pathogens (Basel, Switzerland) 2020; (9(4)) doi:10.3390/pathogens9040292.

    PMID: 32316236
  49. 49

    Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer.

    Zusterzeel PLM, Aarts JWM, Pol FJM, et al.

    The oncologist 2020; (25(7)):e1051-e1059 doi:10.1634/theoncologist.2020-0063.

    PMID: 32339376
  50. 50

    The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.

    Hwang WY, Kim JH, Suh DH, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(7)):975-980 doi:10.1136/ijgc-2020-001271.

    PMID: 32467336
  51. 51

    Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer: A Systematic Review and Meta-analysis.

    Nitecki R, Ramirez PT, Frumovitz M, et al.

    JAMA oncology 2020; (6(7)):1019-1027 doi:10.1001/jamaoncol.2020.1694.

    PMID: 32525511
  52. 52

    Multimodality Imaging of Uterine Cervical Malignancies.

    Mansoori B, Khatri G, Rivera-Colón G, et al.

    AJR. American journal of roentgenology 2020; (215(2)):292-304 doi:10.2214/AJR.19.21941.

    PMID: 32551909
  53. 53

    Laparoscopic versus open radical hysterectomy in women with early stage cervical cancer: A systematic review and meta-analysis.

    Tantitamit T, Huang KG, Lee CL

    Taiwanese journal of obstetrics & gynecology 2020; (59(4)):481-488 doi:10.1016/j.tjog.2020.05.003.

    PMID: 32653117
  54. 54

    How should we stage and tailor treatment strategy in locally advanced cervical cancer? Imaging versus para-aortic surgical staging.

    Martinez A, Angeles MA, Querleu D, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(9)):1434-1443 doi:10.1136/ijgc-2020-001351.

    PMID: 32788263
  55. 55

    Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review.

    Bona AF, Ferreira KR, Carvalho RBM, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020; (30(11)):1697-1704 doi:10.1136/ijgc-2020-001682.

    PMID: 32863276
  56. 56

    Emergency Embolization of Pelvic Vessels in Patients With Locally Advanced Cervical Cancer and Massive Vaginal Bleeding: A Case Series in a Latin American Oncological Center.

    Alméciga A, Rodriguez J, Beltrán J, et al.

    JCO global oncology 2020; (6()):1376-1383 doi:10.1200/GO.20.00239.

    PMID: 32903119
  57. 57

    Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.

    Kim J, Cho Y, Kim N, et al.

    Gynecologic oncology 2021; (160(3)):735-741 doi:10.1016/j.ygyno.2020.12.012.

    PMID: 33358037
  58. 58

    Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study.

    Chao X, Fan J, Song X, et al.

    Frontiers in oncology 2020; (10()):591253 doi:10.3389/fonc.2020.591253.

    PMID: 33365270
  59. 59

    Risk factors for HPV infection and high-grade cervical disease in sexually active Japanese women.

    Yamaguchi M, Sekine M, Hanley SJB, et al.

    Scientific reports 2021; (11(1)):2898 doi:10.1038/s41598-021-82354-6.

    PMID: 33536516
  60. 60

    Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

    Tsuyoshi H, Tsujikawa T, Yamada S, et al.

    Diagnostics (Basel, Switzerland) 2021; (11(2)) doi:10.3390/diagnostics11020202.

    PMID: 33573078
  61. 61

    MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.

    Pötter R, Tanderup K, Schmid MP, et al.

    The Lancet. Oncology 2021; (22(4)):538-547 doi:10.1016/S1470-2045(20)30753-1.

    PMID: 33794207
  62. 62

    MRI-Directed Brachytherapy for Cancer of the Uterine Cervix: A Case Report, Review, and Perspective on the Importance of Widespread Use of This Technological Advance in the United States.

    Ahmed HZ, Vijayakumar S, Duggar WN, Allbright R

    Cureus 2021; (13(6)):e15495 doi:10.7759/cureus.15495.

    PMID: 34113529
  63. 63

    HPV-negative Squamous Cell Carcinomas of the Cervix With Special Focus on Intraepithelial Precursor Lesions.

    Regauer S, Reich O, Kashofer K

    The American journal of surgical pathology 2022; (46(2)):147-158 doi:10.1097/PAS.0000000000001778.

    PMID: 34387215
  64. 64

    ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.

    Schmeler KM, Pareja R, Lopez Blanco A, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021; (31(10)):1317-1325 doi:10.1136/ijgc-2021-002921.

    PMID: 34493587
  65. 65

    Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma.

    Rychlik A, Querleu D, Bidzinski M

    Cancers 2021; (13(20)) doi:10.3390/cancers13205177.

    PMID: 34680326
  66. 66

    Assessment of pulmonary embolism severity and the risk of early death.

    Pruszczyk P, Skowrońska M, Ciurzyński M, et al.

    Polish archives of internal medicine 2021; (131(12)) doi:10.20452/pamw.16134.

    PMID: 34775739
  67. 67

    Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.

    Korenaga TK, Yoshida EJ, Pierson W, et al.

    Gynecologic oncology 2022; (164(2)):348-356 doi:10.1016/j.ygyno.2021.11.015.

    PMID: 34865860
  68. 68

    Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.

    Westerveld H, Kirchheiner K, Nout RA, et al.

    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2022; (168()):8-15 doi:10.1016/j.radonc.2021.12.034.

    PMID: 35063582
  69. 69

    Utility of routine cytology in detecting asymptomatic cervical cancer recurrence.

    McDowell JL, Young AJ, Daucher JA, Purinton SC

    Journal of the American Society of Cytopathology 2022; (11(3)):173-179 doi:10.1016/j.jasc.2021.12.004.

    PMID: 35074286
  70. 70

    Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome.

    Singhal S, Veeratterapillay J, Locks S, et al.

    Clinical oncology (Royal College of Radiologists (Great Britain)) 2022; (34(7)):442-451 doi:10.1016/j.clon.2022.01.039.

    PMID: 35123850
  71. 71

    An updated narrative review on the management of the most common oncological and hematological emergencies.

    Issani A

    Disease-a-month : DM 2023; (69(2)):101355 doi:10.1016/j.disamonth.2022.101355.

    PMID: 35379468
  72. 72

    How to Care and Minimize the Sequelae of Lower Extremity Lymphedema.

    Bobrek K, Nabavizadeh R, Nabavizadeh B, Master V

    Seminars in oncology nursing 2022; (38(3)):151270 doi:10.1016/j.soncn.2022.151270.

    PMID: 35431083
  73. 73

    Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis.

    Huang K, Xu L, Jia M, et al.

    Aging 2022; (14(9)):3836-3855 doi:10.18632/aging.204047.

    PMID: 35507749
  74. 74

    GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee.

    Woopen H, Sehouli J, Davis A, et al.

    Cancer treatment reviews 2022; (107()):102396 doi:10.1016/j.ctrv.2022.102396.

    PMID: 35525106
  75. 75

    Imaging Biomarkers and Liquid Biopsy in Assessment of Cervical Cancer.

    Ghani MA, Liau J, Eskander R, et al.

    Journal of computer assisted tomography 2022; (46(5)):707-715 doi:10.1097/RCT.0000000000001358.

    PMID: 35995483
  76. 76

    Endometrial serous carcinoma with extensive squamous differentiation mimicking primary endometrial squamous cell carcinoma: Clinicopathological and molecular analysis of a case with literature review.

    Santoro A, Travaglino A, Arciuolo D, et al.

    Pathology, research and practice 2022; (240()):154209 doi:10.1016/j.prp.2022.154209.

    PMID: 36423403
  77. 77

    Acute kidney injury due to bilateral malignant ureteral obstruction: Is there an optimal mode of drainage?

    Gadelkareem RA, Abdelraouf AM, El-Taher AM, Ahmed AI

    World journal of nephrology 2022; (11(6)):146-163 doi:10.5527/wjn.v11.i6.146.

    PMID: 36530794
  78. 78

    The Histologic and Molecular Spectrum of Highly Differentiated HPV-independent Cervical Intraepithelial Neoplasia.

    Regauer S, Reich O

    The American journal of surgical pathology 2023; (47(8)):942-949 doi:10.1097/PAS.0000000000002067.

    PMID: 37283469
  79. 79

    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.

    Mauro J, Viveros-Carreño D, Vizzielli G, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2023; (33(9)):1370-1375 doi:10.1136/ijgc-2023-004692.

    PMID: 37586759
  80. 80

    Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.

    Stolnicu S, Allison D, Patrichi A, et al.

    Advances in anatomic pathology 2024; (31(1)):1-14 doi:10.1097/PAP.0000000000000411.

    PMID: 37638549
  81. 81

    Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.

    Stolnicu S, Allison D, Praiss AM, et al.

    The American journal of surgical pathology 2023; (47(12)):1376-1389 doi:10.1097/PAS.0000000000002122.

    PMID: 37702216
  82. 82

    Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

    Ye J, Zheng L, He Y, Qi X

    MedComm 2023; (4(5)):e368 doi:10.1002/mco2.368.

    PMID: 37719443
  83. 83

    Definitive irradiation as a first treatment strategy for primary and metastatic sites of newly diagnosed IVB cervical cancer that presented with synchronous oligometastases.

    Li J, Wang Y, Huo L, et al.

    Radiation oncology (London, England) 2023; (18(1)):159 doi:10.1186/s13014-023-02320-6.

    PMID: 37752606
  84. 84

    A case report of lung metastasis in a cervical cancer presenting as a consolidation.

    Abughazaleh S, Tarawneh M, Alzghoul H, et al.

    Radiology case reports 2024; (19(3)):1144-1148 doi:10.1016/j.radcr.2023.11.054.

    PMID: 38234387
  85. 85

    Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.

    Salman L, Covens A

    Current oncology (Toronto, Ont.) 2024; (31(1)):296-306 doi:10.3390/curroncol31010019.

    PMID: 38248104
  86. 86

    International Anal Neoplasia Society's consensus guidelines for anal cancer screening.

    Stier EA, Clarke MA, Deshmukh AA, et al.

    International journal of cancer 2024; (154(10)):1694-1702 doi:10.1002/ijc.34850.

    PMID: 38297406
  87. 87

    Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer - a nationwide Dutch cohort study.

    Olthof EP, Bergink-Voorthuis BJ, Wenzel HHB, et al.

    Insights into imaging 2024; (15(1)):36 doi:10.1186/s13244-023-01589-1.

    PMID: 38332397
  88. 88

    Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report.

    Ge J, Weng C, Zhao J, et al.

    Frontiers in cardiovascular medicine 2024; (11()):1351358 doi:10.3389/fcvm.2024.1351358.

    PMID: 38385133
  89. 89

    Outcome and toxicity of chemoradiation using volumetric modulated arc therapy followed by 3D image-guided brachytherapy for cervical cancer: Vietnam National Cancer Hospital experience.

    Van Anh DT, Thang VH, Dung TA, et al.

    Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 2023; (28(6)):784-793 doi:10.5603/rpor.98735.

    PMID: 38515819
  90. 90

    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

    Lorusso D, Xiang Y, Hasegawa K, et al.

    Lancet (London, England) 2024; (403(10434)):1341-1350 doi:10.1016/S0140-6736(24)00317-9.

    PMID: 38521086
  91. 91

    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.

    Kohler C, Plaikner A, Siegler K, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024; (34(6)):799-805.

    PMID: 38599782
  92. 92

    A Rare Encounter With Unusual Metastasis: Metastatic Right Ventricular Tumor Secondary to Cervical Cancer.

    Nnadi EN, Khatun N, John S

    Cureus 2024; (16(6)):e62530 doi:10.7759/cureus.62530.

    PMID: 39022461
  93. 93

    The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Cervical Cancer (v2024.0).

    Sznurkowski JJ, Bodnar L, Szylberg Ł, et al.

    Journal of clinical medicine 2024; (13(15)) doi:10.3390/jcm13154351.

    PMID: 39124620
  94. 94

    Case report: Clinicopathological characteristic of two cases of primary endometrial squamous cell carcinoma and review of the literature.

    Zhang HB, Lin LH, Lin QP, et al.

    Frontiers in oncology 2024; (14()):1415816 doi:10.3389/fonc.2024.1415816.

    PMID: 39252944
  95. 95

    Association Between the Regular Use of Vaginal Dilators and/or Sexual Activity and Vaginal Morbidity in Locally Advanced Cervical Cancer Survivors: An EMBRACE-I Study Report.

    Kirchheiner K, Zaharie A, Smet S, et al.

    International journal of radiation oncology, biology, physics 2025; (121(2)):452-464 doi:10.1016/j.ijrobp.2024.09.011.

    PMID: 39278418
  96. 96

    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.

    Lorusso D, Xiang Y, Hasegawa K, et al.

    Lancet (London, England) 2024; (404(10460)):1321-1332 doi:10.1016/S0140-6736(24)01808-7.

    PMID: 39288779
  97. 97

    Non-dilated obstructive nephropathy.

    Feliciangeli V, Noce A, Montalto G, et al.

    Clinical kidney journal 2024; (17(10)):sfae249 doi:10.1093/ckj/sfae249.

    PMID: 39391590
  98. 98

    An unusual pattern of endometrial involvement: superficial spreading squamous cell carcinoma of the cervix.

    Jiang X, Han Z, Chun Z, et al.

    Frontiers in oncology 2024; (14()):1456297 doi:10.3389/fonc.2024.1456297.

    PMID: 39411132
  99. 99

    Stage migration and survival outcomes in patients with cervical cancer at Stage IIIC according to the 2018 FIGO staging system: a systematic review and meta-analysis.

    Han L, Chen Y, Zheng A, et al.

    Frontiers in oncology 2024; (14()):1460543 doi:10.3389/fonc.2024.1460543.

    PMID: 39411135
  100. 100

    Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency.

    Pepin A, Chesnokova A, Pishko A, et al.

    International journal of radiation oncology, biology, physics 2025; (121(4)):1042-1052 doi:10.1016/j.ijrobp.2024.10.023.

    PMID: 39448037
  101. 101

    Cervical Human Papillomavirus-Independent Squamous Cell Carcinoma: A Clinicopathological Review and Outcomes Analysis Compared With Human Papillomavirus-Associated Squamous Cell Carcinoma.

    Stolnicu S, Rakislova N, Morató A, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2025; (38(6)):100742 doi:10.1016/j.modpat.2025.100742.

    PMID: 40010435
  102. 102

    The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer patients after surgery.

    Wang Y, Wang M, Zhu L

    Journal of gynecologic oncology 2025; (36(4)):e65 doi:10.3802/jgo.2025.36.e65.

    PMID: 40223551
  103. 103

    After Radical Trachelectomy: Reproductive and Obstetrical Outcomes of Fertility-Sparing Surgery for Cervical Cancer.

    Soltanizadeh S, Rosendahl M, Frøding LP, et al.

    Seminars in reproductive medicine 2025; (43(1)):11-15 doi:10.1055/s-0045-1808092.

    PMID: 40245928
  104. 104

    HPV-independent squamous sell carcinoma of cervix: a clinicopathological, immunohistochemical, and molecular analysis of six cases.

    Kır G, Erbağcı A, Özen F, et al.

    Virchows Archiv : an international journal of pathology 2025; (487(4)):775-786 doi:10.1007/s00428-025-04113-6.

    PMID: 40347270
  105. 105

    Eternal dilemma between percutaneous nephrostomy and double J stenting in the management of patients with ureteral obstruction: A single center study.

    Baio R, Molisso G, Perpetuini D, et al.

    Biomedical reports 2025; (23(1)):108 doi:10.3892/br.2025.1986.

    PMID: 40364904
  106. 106

    MRI-based image-guided adaptive brachytherapy for locally advanced cervical cancer in clinical routine: a single-institution experience.

    Végváry Z, Kószó R, Együd Z, et al.

    Pathology oncology research : POR 2025; (31()):1612077 doi:10.3389/pore.2025.1612077.

    PMID: 40376012
  107. 107

    Oxidative Stress, Inflammation, and Antioxidant Strategies in Cervical Cancer-A Narrative Review.

    Tomaziu-Todosia Anton E, Anton GI, Scripcariu IS, et al.

    International journal of molecular sciences 2025; (26(10)) doi:10.3390/ijms26104961.

    PMID: 40430101
  108. 108

    Risk factors for lower limb lymphedema after gynecological cancer treatment: a systematic review.

    Decorte T, Cerckel M, Kheir GB, et al.

    Frontiers in oncology 2025; (15()):1561836 doi:10.3389/fonc.2025.1561836.

    PMID: 40463868
  109. 109

    2024 SOGC, 2024 NCCN, 2022 ESO-ESMO, and 2018 ASCO: a comparison of female cancer survivorship guidelines for the management of sexual health concerns.

    Bhinder JK, Kennedy SKF, Faouk Al Aadah C, Al-Khaifi M

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2025; (33(7)):584 doi:10.1007/s00520-025-09640-1.

    PMID: 40518469
  110. 110

    Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer.

    Randall L, Xiang Y, Matsumoto T, et al.

    Gynecologic oncology 2025; (199()):88-95 doi:10.1016/j.ygyno.2025.06.003.

    PMID: 40592026
  111. 111

    The TP53 "rs 1042522″ Polymorphism and its association with precancerous cervical lesions progression among Tunisian women.

    Ben Jemia Z, Fehri E, Ardhaoui M, et al.

    Diagnostic microbiology and infectious disease 2025; (113(3)):116981 doi:10.1016/j.diagmicrobio.2025.116981.

    PMID: 40609119
  112. 112

    Near-fatal saddle pulmonary embolism following chemoradiotherapy and brachytherapy for locally advanced cervical cancer: A case series.

    Leijtens L, Piek J, Kamps M, et al.

    Journal of contemporary brachytherapy 2025; (17(3)):197-201 doi:10.5114/jcb.2025.152543.

    PMID: 40697723
  113. 113

    Management of Neutropenic Fever in Persons with Cancer.

    Doyle-Lindrud S

    The Nursing clinics of North America 2025; (60(3)):479-489 doi:10.1016/j.cnur.2024.09.004.

    PMID: 40716808
  114. 114

    Diagnostic value of cytology in detecting human papillomavirus-independent cervical malignancies: a nation-wide study in Korea.

    Jung HR, Shin J, Yoo CW, et al.

    Journal of pathology and translational medicine 2025; (59(6)):444-452 doi:10.4132/jptm.2025.10.21.

    PMID: 41266097
  115. 115

    Role of human papillomavirus status in the classification, diagnosis, and prognosis of malignant cervical epithelial tumors and precursor lesions.

    Stolnicu S

    Pathologie (Heidelberg, Germany) 2025; doi:10.1007/s00292-025-01517-8.

    PMID: 41335338
  116. 116

    Impact of high-dose pelvic radiotherapy combined with chemotherapy on local control, symptom relief, and safety in patients with stage IVB cervical cancer (FIGO 2018): a two-center retrospective study.

    Nakashima T, Matsumoto K, Yoshitake T, et al.

    Japanese journal of radiology 2026; (44(4)):719-729 doi:10.1007/s11604-025-01923-1.

    PMID: 41441948
  117. 117

    HPV-Driven Cervical Carcinogenesis: Genetic and Epigenetic Mechanisms and Diagnostic Approaches.

    Legaki E, Lappa T, Prasoula KL, et al.

    International journal of molecular sciences 2026; (27(2)) doi:10.3390/ijms27020803.

    PMID: 41596450
  118. 118

    Patient experiences of radiation-induced menopause in cervical cancer: A scoping review.

    Jacques LJ, Clarkson M, Humphrey PM

    Radiography (London, England : 1995) 2026; (32(3)):103345 doi:10.1016/j.radi.2026.103345.

    PMID: 41679255
  119. 119

    Fluoroscopy-guided transurethral resection with antegrade guidewire assistance for retrieval of a buried double-J stent: A case report.

    Deligiannis P, Katsimperis S, Kyriazis I, et al.

    World journal of clinical cases 2026; (14(5)):117384 doi:10.12998/wjcc.v14.i5.117384.

    PMID: 41700183
  120. 120

    Refinement in radiotherapy treatment for locally advanced cervical cancer: a historic perspective.

    Caicedo-Martínez M, Arbeláez-Mariño AF, Arbeláez L, et al.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2026; 102878 doi:10.1016/j.ijgc.2025.102878.

    PMID: 41775566
  121. 121

    Neoplastic Cauda Equina Syndrome: When Do We Not Operate?

    Jain H, Sarikonda A, Potter T, et al.

    Neurosurgery practice 2026; (7(2)):e000220 doi:10.1227/neuprac.0000000000000220.

    PMID: 41982315
  122. 122

    Comparative Outcomes of Survival and Relapse After High-Dose-Rate Brachytherapy Versus External-Beam Radiotherapy Boost Following Concurrent Chemoradiation in Locally Advanced Cervical Cancer in Algeria.

    Benarbia M, Boukerche A

    JCO global oncology 2026; (12(4)):e2500664 doi:10.1200/GO-25-00664.

    PMID: 42024843
  123. 123

    Brachytherapy use in cervical cancer: a narrative review.

    Moorthy A, Le NA, Issac A, et al.

    Gynecology and pelvic medicine 2026; (9()):8 doi:10.21037/gpm-25-44.

    PMID: 42212287
  124. 124

    The interplay between HPV, vaginal microbiota and host immunity in cervical carcinogenesis.

    Moghaddam NA, Mohabbat A, Jigheh MP, et al.

    Discover oncology 2026; (17(1)).

    PMID: 42223784
  125. 125

    Evidence-based management of metastatic spinal cord compression (MSCC): expert recommendations for standardizing care in Spain.

    Conde-Moreno AJ, Pérez-Lara A, Ferrer-Abiach C, et al.

    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026; doi:10.1007/s12094-026-04345-1.

    PMID: 42228280
  126. 126

    Conversion-oriented multimodal therapy enabling definitive surgery in a patient with FIGO stage IVA cervical cancer at high risk of fistula formation: a case report.

    Yuan Y, He W, Tong L, et al.

    Frontiers in immunology 2026; (17()):1853610 doi:10.3389/fimmu.2026.1853610.

    PMID: 42389528
  127. 127

    Clinical Outcomes and Prognostic Factors Following Routine CT-Based Image-Guided Adaptive Brachytherapy for Cervical Cancer: A Retrospective Cohort Study.

    Muangwong P, Tharavichitkul E, Chakrabandhu S, et al.

    Cancers 2026; (18(17)) doi:10.3390/cancers18172805.

    PMID: 42738326